Eyenovia
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Eyenovia sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Eyenovia: 7 sponsored US clinical trials, none currently recruiting.
Eyenovia sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 6 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Presbyopia, with 2 trials.
Upper-quartile sponsor footprint
Eyenovia sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation
NCT06217796
Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults
NCT05114486
Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults
NCT04657172
Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression
NCT03942419
Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation
NCT03751098
Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation
NCT03751631
Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil
NCT02946125
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 5 |
| Phase 4 | 1 |
Therapeutic Areas
How the Eyenovia archive is shaped
7 indexed studies, none listed as recruiting (0% open); 6 completed (86%).
Phase mix: 6 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Presbyopia (2 trials), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Eyenovia: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Eyenovia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Eyenovia page
7 registered trials is a research-attention snapshot, not an endorsement of Eyenovia or any single study.
- None of Eyenovia's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Presbyopia is the condition Eyenovia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Presbyopia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Eyenovia pipeline card: 7 registered trials from official public datasets.Report a data error.